心不全における単錠剤併用療法 (ポリピル) の使用に対する態度:患者と医師の視点

Jan Biegus^1,2, Rafał Tymków¹, Javed Butler^3,4

¹Jan Mikulicz Radecki University Hospital in Wrocław, Poland.

ESC heart failure

|February 19, 2026

まとめ

医師や心不全の患者は,治療を簡素化し,錠剤の負担を軽減するために,単一錠剤の組み合わせ (SPC) を強く支持しています. これは,心不全 (HF) のポリピル戦略の開発の重要な必要性を示している.

科学分野:

心臓病学心臓病学
薬理学薬理学とは
患者のアデファレンス

背景:

心不全 (HF) の患者は,しばしば複数の薬を管理し,重要な錠剤負担と遵守の課題につながります.
シングル・ピル・コンビネーション (SPC) は,他の心血管領域でも有効ですが,現在,HF患者には利用できません.
HF特有のSPCは,治療レジメンを簡素化し,患者のアウトカムを改善することができます.

研究の目的:

心不全 (HF) のための潜在的な単一錠剤組合せ (SPC) に対する医師と患者の態度を評価する. 射出分数は50%未満.
ガイドライン指向医療療法 (GDMT) の最適化に対する障壁を特定し,HF特有のSPCの好ましい構成要素を特定する.

主な方法:

HFの医師と患者を対象とした2つの将来的な電子調査 (2025年6月〜10月) が実施されました.
医者の調査は,GDMTの実践,ニーズ,障壁,および好みのSPC組成を調べました.
患者アンケートでは,薬の負担,服従,ポリピル使用に対する認識が評価されました.

主要な成果:

大多数の医師 (77%) は,GDMTを簡素化する必要性を認識し,コストとポリファーマシーを主要な障壁として挙げました.
医師の95%が,HF特有のSPCの臨床的必要性を認識し,臨床的に有用 (88%) と実現可能 (76%) と判断しました.
ほとんどの患者 (75%) は,ポリファーマシー (毎日≥6薬) による偶発的な不遵守を報告しました; 83% は,特に追加費用なしで,提供されれば,HF特有のSPCを取ります.

結論:

医師も患者も,HF特有のSPCに対する強い意思とオープン性を表明しました.
この発見は,心不全管理のためのポリピル戦略のさらなる開発と評価を支持します.

キーワード:

GDMTTは,GDMTという名前でポリピル・ポリピルとはシングルピルの組み合わせです.

さらに関連する動画

05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K

関連する概念動画

01:30

Heart Failure V: Medical Management

388

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

388

01:22

Heart Failure Drugs: β-Blockers

992

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...

992

01:27

Coronary Artery Disease V: Interprofessional Care

320

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

320

01:28

Drug Therapy

316

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

316

01:15

Drug Dosing: Geriatric Patients

306

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

306

01:22

Heart Failure VI: Adjunct Therapies

428

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

428

関連する実験動画